Concurrent Investment Advisors LLC Acquires 83,094 Shares of CVS Health Corporation $CVS

Concurrent Investment Advisors LLC increased its stake in shares of CVS Health Corporation (NYSE:CVS) by 274.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 113,425 shares of the pharmacy operator’s stock after purchasing an additional 83,094 shares during the quarter. Concurrent Investment Advisors LLC’s holdings in CVS Health were worth $11,734,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Kilter Group LLC acquired a new position in shares of CVS Health during the second quarter valued at about $27,000. Beaird Harris Wealth Management LLC boosted its holdings in CVS Health by 201.0% during the 2nd quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 195 shares during the period. J.Safra Asset Management Corp purchased a new position in CVS Health during the 2nd quarter valued at $30,000. Dunhill Financial LLC bought a new stake in shares of CVS Health during the 2nd quarter valued at $32,000. Finally, Swiss RE Ltd. bought a new stake in shares of CVS Health during the 4th quarter valued at $26,000. 80.66% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on the stock. Argus boosted their price objective on shares of CVS Health from $104.00 to $114.00 and gave the stock a “buy” rating in a research note on Wednesday, August 19th. Robert W. Baird set a $107.00 target price on CVS Health in a report on Thursday, August 6th. Royal Bank Of Canada lifted their price target on CVS Health from $107.00 to $113.00 and gave the stock an “outperform” rating in a research report on Thursday, July 9th. Wall Street Zen raised shares of CVS Health from a “buy” rating to a “strong-buy” rating in a report on Saturday, August 8th. Finally, Piper Sandler reiterated an “overweight” rating on shares of CVS Health in a report on Wednesday, August 26th. Twenty-two analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $106.83.

CVS Health Stock Performance

Shares of CVS opened at $96.80 on Friday. The firm has a market capitalization of $123.80 billion, a P/E ratio of 25.61, a PEG ratio of 0.95 and a beta of 0.59. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. The business has a fifty day moving average of $100.79 and a 200 day moving average of $90.14. CVS Health Corporation has a one year low of $69.51 and a one year high of $110.68.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping the consensus estimate of $1.87 by $0.71. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The firm had revenue of $106.10 billion for the quarter, compared to analysts’ expectations of $100.03 billion. During the same quarter in the prior year, the business earned $1.81 EPS. The business’s quarterly revenue was up 7.3% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, sell-side analysts anticipate that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend was Thursday, July 23rd. CVS Health’s payout ratio is presently 70.37%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.